Amlodipine Besylate/Candesartan Cilexetil

苯磺酸氨氯地平/坎地沙坦酯

Report date: 2024/07/17 20:00:53

Base Information

Drug NameAmlodipine Besylate/Candesartan Cilexetil
Drug Alias Nameカンデサルタンシレキセチル・アムロジピンベシル酸塩配合剤坎地沙坦酯苯磺酸氨氯地平Candesartan cilexetil and anmlodipine besylate坎地沙坦酯/苯磺酸氨氯地平Candesartan cilexetil - amlodipine besilate mixt +[15] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2010/04/06
Country/TerritoryMainland ChinaJapan
CombinationsYes Candesartan CilexetilAmlodipine Besylate
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCheplapharm Arzneimittel GmbhTakeda Pharmaceutical Co LtdJiangxi Shimei Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DB07
Related LinksKEGG